Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-[2-ethanesulfonylamino-3-(5-propoxy-1H-indol-3-yl)-propionylamino]-pentanedioic acid 5-amide 1-(4-carbamimidoyl-benzylamide)
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is an experimental small molecule dipeptide containing several notable structural elements including an indole ring and amidine group. It has not been approved for any indication and there are no clinical trials or regulatory approvals reported. Its mechanism of action and biological targets have not been described in the available literature. The compound is referenced in chemical databases such as DrugBank (DB04606), PubChem (SID 46507880), ChemSpider (ID 4484180), and RCSB PDB as ligand "5PI". It is primarily of interest for research purposes[2][8][10].
- Other names
- DB04606DB-04606DB 04606L-glutamamide, N-(ethylsulfonyl)-5-propoxy-D-tryptophyl-N~1~-(4-carbamimidoylbenzyl)-L-glutamamidN-(ethylsulfonyl)-5-propoxy-D-tryptophyl-N~1~-(4-carbamimidoylbenzyl)-L-glutamamide(2S)-N-[(4-carbamimidoylphenyl)methyl]-2-[(2R)-2-ethanesulfonamido-3-(5-propoxy-1H-indol-3-yl)propanamido]pentanediamide5PI
02
Targets
F7 (Coagulation Factor VII)
Beyond the preview
Go deeper on 2-[2-ethanesulfonylamino-3-(5-propoxy-1H-indol-3-yl)-propionylamino]-pentanedioic acid 5-amide 1-(4-carbamimidoyl-benzylamide).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-[2-ethanesulfonylamino-3-(5-propoxy-1H-indol-3-yl)-propionylamino]-pentanedioic acid 5-amide 1-(4-carbamimidoyl-benzylamide).